Text Size
119 studies found for:    folate receptor

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Unknown † The Development of Human Immunologic Assays Specific to Folate Receptor Antigen
Condition: Ovarian Cancer
Intervention: Procedure: venous puncture
2 Unknown † Measurement of the Folate Receptor in Blood
Condition: Healthy
Intervention:
3 Unknown † FR in Stored Plasma
Condition: Ovarian Cancer
Intervention:
4 Recruiting Does Valproate Increase Levels of Folate Receptor Autoantibodies in Women?
Conditions: Epilepsy;   Psychiatric Conditions
Intervention:
5 Completed Study Using FolateScan to Identify Subjects With Folate Receptor-Positive Metastatic Renal Cell Carcinoma
Condition: Metastatic Renal Cell Carcinoma
Intervention: Drug: Technetium Tc 99m EC20
6 Recruiting Cyclophosphamide and Vaccine Therapy in Treating Patients With Stage II-III Breast, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Conditions: Recurrent Breast Cancer;   Recurrent Fallopian Tube Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Ovarian Germ Cell Tumor;   Recurrent Primary Peritoneal Cavity Cancer;   Stage IIA Ovarian Epithelial Cancer;   Stage IIA Ovarian Germ Cell Tumor;   Stage IIA Primary Peritoneal Cavity Cancer;   Stage IIB Ovarian Epithelial Cancer;   Stage IIB Ovarian Germ Cell Tumor;   Stage IIB Primary Peritoneal Cavity Cancer;   Stage IIC Ovarian Epithelial Cancer;   Stage IIC Ovarian Germ Cell Tumor;   Stage IIC Primary Peritoneal Cavity Cancer;   Stage IIIA Breast Cancer;   Stage IIIA Ovarian Epithelial Cancer;   Stage IIIA Ovarian Germ Cell Tumor;   Stage IIIA Primary Peritoneal Cavity Cancer;   Stage IIIB Breast Cancer;   Stage IIIB Ovarian Epithelial Cancer;   Stage IIIB Ovarian Germ Cell Tumor;   Stage IIIB Primary Peritoneal Cavity Cancer;   Stage IIIC Breast Cancer;   Stage IIIC Ovarian Epithelial Cancer;   Stage IIIC Ovarian Germ Cell Tumor;   Stage IIIC Primary Peritoneal Cavity Cancer
Interventions: Drug: Cyclophosphamide;   Biological: multi-epitope folate receptor alpha peptide vaccine;   Other: laboratory biomarker analysis
7 Active, not recruiting A Study of MORAb-003 in Patients With Solid Tumor
Condition: Patients With a Folate-receptor Alpha Expressing Solid Tumor Who Are Not Responsive or Resistant to Standard Therapy and Have no Other Appropriate Treatment.
Intervention: Drug: MORAb-003
8 Recruiting Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Interventions: Drug: EC145;   Drug: EC145 + Docetaxel;   Drug: Docetaxel;   Drug: EC20
9 Completed Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid Tumor
Conditions: Recurrent or Metastatic Cancer;   Head and Neck Cancer;   Pancreas Cancer;   Bladder Cancer;   Testicular Cancer
Intervention: Drug: Tc 99m EC20
10 Completed Safety and Efficacy of Folatescan (Technetium TC 99M EC20) in Patients With Suspected Ovarian Carcinoma or Recurrent Endometrial Carcinoma
Conditions: Ovarian Carcinoma;   Recurrent Endometrial Carcinoma
Intervention: Drug: Tc 99m EC20
11 Recruiting A Folinic Acid Intervention for Autism Spectrum Disorders
Conditions: Autism Spectrum Disorder;   Autistic Disorder;   Autism;   Asperger's Syndrome;   Pervasive Development Disorders
Interventions: Drug: Folinic Acid and placebo;   Drug: Folinic Acid
12 Completed Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Pituitary Tumors
Condition: Pituitary Tumors
Intervention: Drug: Technetium Tc 99m EC20
13 Completed Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Suspected Metastatic Renal Cell Carcinoma
Condition: Metastatic Renal Cell Carcinoma
Intervention: Drug: Tc 99m EC20
14 Completed Radiolabeled Folic Acid and Imaging to Detect Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Procedure: radionuclide imaging;   Radiation: indium In 111 folic acid
15 Terminated Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal Cancer
Conditions: Ovarian Cancer;   Peritoneal Cancer
Intervention: Drug: Gemzar and Alimta
16 Terminated An Exploratory, Randomized, Blinded, Placebo-Controlled Trial of Folic Acid and L-methylfolate in Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Dietary Supplement: Folic Acid, Vitamin B6, Vitamin B12;   Dietary Supplement: B6, B12, L-methylfolate;   Dietary Supplement: B6, B12, Placebo
17 Active, not recruiting Intra-op Detection of Occult Ovarian Carcinoma Using a Folate-Alpha Receptor Specific Fluorescent Ligand
Condition: Ovarian Cancer
Intervention: Drug: EC-17
18 Recruiting A Study of MK-8109 (Vintafolide) Given With Chemotherapy in Participants With Advanced Cancers (MK-8109-001)
Condition: Advanced Cancer
Interventions: Drug: Vintafolide;   Drug: Carboplatin;   Drug: Paclitaxel
19 Completed Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based Chemotherapy
Condition: Nasopharyngeal Neoplasms
Intervention: Drug: Pemetrexed (Alimta)
20 Unknown † Tumor Response to Pemetrexed Disodium in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Enrolled in Clinical Trial MCCRC-RC0524
Condition: Lung Cancer
Interventions: Genetic: gene expression analysis;   Genetic: polymorphism analysis;   Genetic: protein expression analysis
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years